July 25, 2014 6:28 AM ET

Pharmaceuticals

Company Overview of INO Therapeutics LLC

Company Overview

INO Therapeutics LLC manufactures and markets pharmaceutical drugs and devices for the treatment of hypoxic respiratory failure in newborns. It provides pharmaceutical products under the INOmax brand name. It was formerly known as INOCO, Inc. and changed its name to INO Therapeutics LLC in November 2003. The company was founded in 1998 and is based in Clinton, New Jersey. As of March 27, 2007, INO Therapeutics LLC operates as a subsidiary of Ikaria, Inc.

6 Route 173 West

Clinton, NJ 08809

United States

Founded in 1998

Phone:

908-238-6600

Fax:

908-238-6633

Key Executives for INO Therapeutics LLC

INO Therapeutics LLC does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
RelaxZen, Inc. United States
Albion Medical Holdings, Inc. United States
Nephron Pharmaceuticals Corporation United States
Cytos Pharmaceuticals L.L.C. United States
Intelligent Biocides, L.L.C. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INO Therapeutics LLC, please visit www.inomax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.